Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes.
<p>Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes.</p>
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1852016662802333696 |
|---|---|
| author | Samira Sanami (13192454) |
| author2 | Shahrzad Aghaamoo (22238490) Sajjad Ahmad (768814) Ali Fazli (18868315) Bahareh Mansouri (16828881) Jonas Ivan Nobre Oliveira (15455466) Mojgan Rahmanian (22238493) |
| author2_role | author author author author author author |
| author_facet | Samira Sanami (13192454) Shahrzad Aghaamoo (22238490) Sajjad Ahmad (768814) Ali Fazli (18868315) Bahareh Mansouri (16828881) Jonas Ivan Nobre Oliveira (15455466) Mojgan Rahmanian (22238493) |
| author_role | author |
| dc.creator.none.fl_str_mv | Samira Sanami (13192454) Shahrzad Aghaamoo (22238490) Sajjad Ahmad (768814) Ali Fazli (18868315) Bahareh Mansouri (16828881) Jonas Ivan Nobre Oliveira (15455466) Mojgan Rahmanian (22238493) |
| dc.date.none.fl_str_mv | 2025-09-12T17:42:22Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0330841.t003 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Binding_free_energy_value_for_VEGFR2-LIF_and_VEGFR2-ponatinib_complexes_/30115401 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biochemistry Cell Biology Genetics Molecular Biology Pharmacology Cancer Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified significant adverse effects pathway enrichment analysis favorable binding energy endometrial tissue outside drug repositioning approaches additional experimental investigations using systems biology ponatinib (&# 8722 limma &# 8221 approved drugs candidates differentially expressed genes xlink "> endometriosis identify hub genes hub genes ponatinib complex drugs designated &# 8220 interacting genes genes involved uterine cavity study indicate study aims search tool r studio promising possibility molecular dynamics identified using gse120103 dataset estrogen insufficiency discover fda david tools cytoscape software assessments suggested 2 kcal 16 fda 100 nanoseconds |
| dc.title.none.fl_str_mv | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_e53393014e2b01deef2d7753afe3bfbd |
| identifier_str_mv | 10.1371/journal.pone.0330841.t003 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30115401 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes.Samira Sanami (13192454)Shahrzad Aghaamoo (22238490)Sajjad Ahmad (768814)Ali Fazli (18868315)Bahareh Mansouri (16828881)Jonas Ivan Nobre Oliveira (15455466)Mojgan Rahmanian (22238493)BiochemistryCell BiologyGeneticsMolecular BiologyPharmacologyCancerBiological Sciences not elsewhere classifiedChemical Sciences not elsewhere classifiedsignificant adverse effectspathway enrichment analysisfavorable binding energyendometrial tissue outsidedrug repositioning approachesadditional experimental investigationsusing systems biologyponatinib (&# 8722limma &# 8221approved drugs candidatesdifferentially expressed genesxlink "> endometriosisidentify hub geneshub genesponatinib complexdrugs designated&# 8220interacting genesgenes involveduterine cavitystudy indicatestudy aimssearch toolr studiopromising possibilitymolecular dynamicsidentified usinggse120103 datasetestrogen insufficiencydiscover fdadavid toolscytoscape softwareassessments suggested2 kcal16 fda100 nanoseconds<p>Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes.</p>2025-09-12T17:42:22ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0330841.t003https://figshare.com/articles/dataset/Binding_free_energy_value_for_VEGFR2-LIF_and_VEGFR2-ponatinib_complexes_/30115401CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/301154012025-09-12T17:42:22Z |
| spellingShingle | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. Samira Sanami (13192454) Biochemistry Cell Biology Genetics Molecular Biology Pharmacology Cancer Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified significant adverse effects pathway enrichment analysis favorable binding energy endometrial tissue outside drug repositioning approaches additional experimental investigations using systems biology ponatinib (&# 8722 limma &# 8221 approved drugs candidates differentially expressed genes xlink "> endometriosis identify hub genes hub genes ponatinib complex drugs designated &# 8220 interacting genes genes involved uterine cavity study indicate study aims search tool r studio promising possibility molecular dynamics identified using gse120103 dataset estrogen insufficiency discover fda david tools cytoscape software assessments suggested 2 kcal 16 fda 100 nanoseconds |
| status_str | publishedVersion |
| title | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| title_full | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| title_fullStr | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| title_full_unstemmed | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| title_short | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| title_sort | Binding free energy value for VEGFR2-LIF and VEGFR2-ponatinib complexes. |
| topic | Biochemistry Cell Biology Genetics Molecular Biology Pharmacology Cancer Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified significant adverse effects pathway enrichment analysis favorable binding energy endometrial tissue outside drug repositioning approaches additional experimental investigations using systems biology ponatinib (&# 8722 limma &# 8221 approved drugs candidates differentially expressed genes xlink "> endometriosis identify hub genes hub genes ponatinib complex drugs designated &# 8220 interacting genes genes involved uterine cavity study indicate study aims search tool r studio promising possibility molecular dynamics identified using gse120103 dataset estrogen insufficiency discover fda david tools cytoscape software assessments suggested 2 kcal 16 fda 100 nanoseconds |